The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

Analyst Patrick Wood from Morgan Stanley maintained a Hold rating on Dexcom (DXCM – Research Report) and keeping the price target at ...

Among its flagship products are the Dexcom G6 and G7 integrated CGM systems, which play an important role in helping individuals monitor their glucose levels effectively. As a prominent player in ...

DexCom is a pioneer in the development of continuous glucose monitoring (CGM) systems, which are used by people managing diabetes. Its innovative devices like the G6 and G7 have set the standard ...

Over the past five years, diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has made meaningful progress on several fronts. The company launched new products in the continuous ...

Mike Kratky, an analyst from Leerink Partners, reiterated the Buy rating on Dexcom (DXCM – Research Report). The associated price target ...

Ladies and gentlemen, welcome to the DexCom Third Quarter 2024 Earnings Release ... on this momentum in Q4 and into 2025. Regarding our DME partnerships, we have worked quickly to refocus on ...

With a market cap of $27.1 billion, DexCom, Inc. (DXCM) is a leading medical device company, specializing in continuous glucose monitoring (CGM) systems for diabetes management. The San Diego ...

Here's why you should take advantage. DexCom ( NASDAQ:DXCM ) Third Quarter 2024 Results Key Financial Results Revenue: US$994.2m (up 2.0% from 3Q 2023). Net... Dexcom stock closed in the red on ...

DexCom's stock crashed after the company lowered its guidance last quarter. The rationale for the adjustment was a bit concerning, prompting analysts to wonder if there are greater problems facing ...

The DME channel experienced share loss, although trends stabilized late in the quarter. Operating income decreased to 21.3% of revenue from 24.5% in the same quarter of 2023. DexCom Inc (NASDAQ:DXCM) ...